Icardiac Technologies Inc Rochester, NY - 14618

Icardiac Technologies Inc is categorized under Neurological Laboratory in Rochester, NY and active since 2006.

Icardiac Technologies Inc was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Neurological Laboratory business, which does work in the B2C market, and is classified as a Neurological Laboratory, under code number 9999900 by the NAICS.

If you are seeking more information, feel free to contact Sasha Latypova, Marketing at the company’s single location by writing to 150 Allens Creek Road # 7, Rochester, New York NY 14618 or by phoning (585) 295-7610. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Icardiac Technologies Inc
Contact Person: Sasha Latypova, Marketing
Address: 150 Allens Creek Road # 7, Rochester, New York 14618
Phone Number: (585) 295-7610
Website Address: icardiac.com
Annual Revenue (USD): Unknown
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Neurological Laboratory
SIC Code: 8071
NAICS Code: 9999900
Share This Business:

Icardiac Technologies Inc was started in 2006 to provide professional Neurological Laboratory under the SIC code 8071 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Sasha Latypova, Marketing for inquiries that concern Icardiac Technologies Inc by calling the company number (585) 295-7610, as your correspondence is most welcome. Additionally, the physical location of the single location of Icardiac Technologies Inc can be found at the coordinates 43.11669,-77.54962 as well as the street address 150 Allens Creek Road # 7 in Rochester, New York 14618.

For its online presence, you may visit Icardiac Technologies Inc’s website at icardiac.com and engage with its social media outlets through on Twitter and on Facebook.